content top

Progression of Myopic Maculopathy After Treatment of Myopic CNV

The progression of myopic maculopathy may affect the long-term VA outcome of myopic CNV treatment. We evaluated the long-term progression of myopic maculopathy and functional outcome after treatment of myopic choroidal neovascularization (CNV) with photodynamic therapy (PDT) and/or intravitrealranibizumab (IVR). This was a retrospective study with a cross-sectional evaluation, including fifty-four eyes with a mean follow-up of 80.6 ± 28.0...

Read More

Myopic Maculopathy – A Review

Pathological myopia (PM) is a leading cause of legal blindness in many developed countries, particularly in young people. It is usually defined as an axial length ≥ 26,5 mm and/or a refractive error of at least -6,00 D and characteristic posterior pole abnormalities. The prevalence of the disease shows a wide variation among different ethnic groups, being higher in Asian populations and lower in African and Pacific Island groups. PM is a...

Read More
content top